Imitrex statdose pen

Sumatriptan 6 mg/0.5 ml Solution for Injection - Summary of Product.

Sumatriptan 6 mg/0.5 ml Solution for Injection - Summary of Product. Prompt treatment allows you to get back to your normal routine and may decrease your need for other pain medications. Jan 29, 2015. Sumatriptan 6 mg/0.5 ml Solution for Injection. 2. Qualitative and quantitative composition. Each pre-filled pen contains 6 mg of sumatriptan.

Drug Profiles <u>IMITREX</u>® for Mraines

Drug Profiles IMITREX® for Mraines Agitation Cardiac arrhythmia: V-fib/V-tach (rare) Dysuria Eye irritation Flushing MI and coronary artery vasospasm in patients with CAD risk factors (extremely rare) Nasal discomfort Palpitations Tingling Weakness Current/history of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes (angina, MI, stroke, TIA, ischemic bowel disease) History of stroke, transient ischemic attack, or hemiplegic or basilar mraine History of coronary artery disease or coronary artery vasospasm Wolff-Parkinson-White syndrome or other cardiac accessory conduction pathway disorders Uncontrolled hypertension DO NOT use IV Within 2 weeks of MAO-A inhibitors Within 24 hours of another 5-HT1 receptor agonist or ergot-type medications Severe hepatic impairment Hypersensitivity Uncontrolled hypertension Use when clear diagnosis of mraine established Equally effective at any stage of mraine, although early use recommended Overuse of acute mraine drugs (eg, ergotamine, triptans, opioids, or combination of these drugs for ≥10 days/month) may lead to exacerbation of headache (medication overuse headache); detoxification may be necessary Binds to melanin, may cause toxicity to melanin-rich tissues on prolonged use Very rare reports of transient and permanent blindness and snificant partial vision loss Serotonin syndrome may occur, particularly during combined use with SSRIs (eg, fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, escitalopram) or SNRIs (eg, venlafaxine, duloxetine); discontinue therapy if it occurs Cerebral/subarachnoid hemorrhage and stroke reported with 5-HT1 agonist administration; discontinue if it occurs Snificant elevation of blood pressure, including hypertensive crisis, reported Not for administration to patients with risk factors for coronary artery disease Use caution in patients with history of seizure disorder or lowered seizure threshold May cause depression including dizziness, weakness, or drowsiness (infrequent); caution when operating heavy machinery Coronary artery vasospasm, transient ischemia, ventricular tachycardia/fibrillation, myocardial infarction, cardiac arrest and death reported with use 5HT1 agonists; perform cardiac evaluation in patients with multiple cardiovascular risk factors; evaluate for coronary artery disease in patients at hh risk; discontinue therapy if arrhythmia occurs Use oral formulations with caution in patients with mild-to-moderate hepatic impairment if treatment necessary and advisable; presystemic clearance, when administered orally, is reduced in hepatic impairment and cause an increase in plasma concentrations; dose reduction recommended; when adminsitered parenterally (SC, intranasal), does not undergo first pass metabolism and may not cause increase in plasma concentrations Pregnancy category: C Embryolethality and blood vessel abnormalities observed with PO or IV doses in pregnant rabbits during organogenesis Lactation: Excreted in breast milk at very low levels (NLM TOXNET); minimize infant to potential exposure by avoiding breastfeeding for 8-12 hours after administration Selective 5-HT1B and 5-HT1D receptor agonist in cranial arteries; elicits vasoconstrictive and anti-inflammatory effects; associated with antidromic neuronal transmission and relief of mraine headache Bioavailability: 15% (PO); 97% (SC) Onset: 10 min (SC); 30 min (PO) Duration: 9-24 hr (SC) Peak plasma time: 0.5-3 hr (PO); 5-20 minutes (SC) Peak plasma concentration: 18-51 ng/m L (PO); 55-108 ng/m L (SC, 6 mg dose) The above information is provided for general informational and educational purposes only. Drug Profiles IMITREX® Injection. CAUTION. The STATdose SYSTEM Kit contains 6-mg dose of injectable IMITREX® and the STATdose PEN® an.

<u>Imitrex</u> <u>Statdose</u> Refill sumatriptan injection medical.

Imitrex Statdose Refill sumatriptan injection medical. Apo-Sumatriptan (CA), Co Sumatriptan (CA), Dom-Sumatriptan (CA), Gen-Sumatriptan (CA), Imran (UK), Imitrex, Novo-Sumatriptan (CA), P-Sumatriptan (CA), PMS-Sumatriptan (CA), Ratio-Sumatriptan (CA), Riva-Sumatriptan (CA), Sandoz Sumatriptan (CA), Sumavel Dose Pro Pharmacologic class: Selective 5-hydroxytryptamine Injection: 6 mg/0.5-ml prefilled syringes, 0.6 mg/0.5-ml single-dose vials; 6 mg/0.5-ml prefilled, single-dose, needle-free subcutaneous delivery system; 4- and 6-mg STATdose system containing two prefilled single-dose syringe cartridges and one STATdose Pen; 4-and 6-mg kits containing two prefilled single-dose syringe cartridges and one autoinjector pen Nasal spray: 5 mg in 100-mcl unit dose spray device (package of six), 20 mg in 100-mcl unit dose spray device (package of six)Tablets: 25 mg, 50 mg, 100 mg Acute mraine, cluster headaches Adults: Initially, 25 mg P. What is Imitrex Statdose Refill sumatriptan injection? Sumatriptan is a headache medicine that narrows blood vessels around the brain. Sumatriptan also reduces.

<u>Pen</u>

Pen To relieve your mraine as soon as possible, use this medicine as soon as the headache pain begins. Learn about Imitrex STATdose Pen subcutaneous - its uses, dosage, side effects, drug interactions, and safety information on RxList.

<u>Imitrex</u> definition of <u>Imitrex</u> by Medical dictionary

Imitrex definition of Imitrex by Medical dictionary Subcutaneous injection of Sumatriptan is indicated for the acute relief of mraine attacks, with or without aura, and for the acute treatment of cluster headache. Looking for online definition of Imitrex in the Medical Dictionary. containing two prefilled single-dose syringe cartridges and one STATdose Pen; 4-and 6-mg.

Sumatriptan Succinate 6mg/0.5ml Injection Refill

Sumatriptan Succinate 6mg/0.5ml Injection Refill Sumatriptan Injection USP, Autoinjector System Marketed by: Dr. Sumatriptan Succinate 6mg/0.5ml Injection Refill 2 Cartridge Pack. Generic Equivalent To Imitrex. Prescription Required Sumatriptan Succinate 6mg/0.5ml.

Can I bring <strong>Imitrex</strong> in my carry on bag? - <strong>statdose</strong> airports.

Can I bring Imitrex in my carry on bag? - statdose airports. It helps to relieve pain and other symptoms of mraines/headaches including sensitivity to lht or sound, nausea, and vomiting. Airport Security Filter Can I bring injectable Imitrex in my carry on bags. Sharps disposal container, pre-loaded syringes, jet injectors, pens.

Generic Product News - Pharmacy Times

Generic Product News - Pharmacy Times Sumatriptan succinate is a white to off-white powder that is readily soluble in water and in saline. Aug 3, 2014. Sumatriptan Injection USP, Autoinjector System Marketed by Dr. Reddy's Laboratories Compare to Imitrex STATdose Pen GlaxoSmithKline

<em>Imitrex</em> <em>STATdose</em> <em>Pen</em> subcutaneous Uses, Side Effects. - WebMD

Imitrex STATdose Pen subcutaneous Uses, Side Effects. - WebMD Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Imitrex Statdose. How to use Imitrex STATdose Pen subcutaneous. Read the Patient Information Leaflet available from your pharmacist before you start using sumatriptan and each time you get a refill.

US English - Safety Data Sheets SDS

US English - Safety Data Sheets SDS Sumatriptan is used to treat mraines and cluster headaches. Nov 6, 2013. SYSTEM * IMITREX STATDOSE PEN * IMITREX INJECTION CATRIDGE PACK * IMITREX. SINGLE DOSE VIAL 6 MG * IMRAN SUBJECT.


Imitrex statdose pen:

Rating: 99 / 100

Overall: 97 Rates

Добавить комментарий

Ваш e-mail не будет опубликован. Обязательные поля помечены *